Report : Asia Pacific Carboxy Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Tabletop, Portable, and Others), Application [Aesthetic Medicine (Cellulite, Stretch Marks, Alopecia, and Dark Under-Eye Circles), Dermatology, Gynecology, Angiology, Orthopedics & Rheumatology, Sports Medicine, and Others], and End User (Hospitals, Aesthetic Clinics, and Wellness Center)
At 12.8% CAGR, the Asia Pacific Carboxy Therapy Market is speculated to be worth US$ 43.49 million by 2028, says Business Market Insights
According to the Insight Partners’ research, the Asia Pacific carboxy therapy market was valued at US$ 21.16 million in 2022 and is expected to reach US$ 43.49 million by 2028, registering a CAGR of 12.8% from 2022 to 2028. Untapped potential of emerging economies and increase in application areas are the critical factors attributed to the Asia Pacific carboxy therapy market expansion.
Carboxy therapy involves the use of carbon dioxide gas as injectables and increasing application areas made it one of the mostly used treatment modalities in dermatology, aesthetic medicine, and anti-aging medicine. As the therapy started gaining traction in the past few years, there has been significant development in the devices used for the treatments. Conventional devices are in the form of pens which are small in size but heavy in nature which makes them difficult to hold during long sessions. This led to the development of devices that are sophisticated in nature and easy to use. Additionally, increased innovations and technological advancements allow multiple puncture techniques for a distance of 1 cm for boluses. Furthermore, leading market players are increasing their penetration across developing markets by expanding their distribution networks and augmenting their production capabilities. Emerging markets in several countries is expected to offer potential growth opportunities for key carboxy therapy device manufacturers in the years to come. This can be attributed to the large patient population, increasing demand for aesthetics, rising interest in anti-aging treatments, increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward the adaption of carboxy therapy.
On the contrary, regulatory policies and safety concerns associated with carbon therapy hurdles the growth of Asia Pacific carboxy therapy market.
Based on type, the market is segmented into tabletop, portable, and others. The tabletop segment held 47.4% share of Asia Pacific carboxy therapy market in 2022, amassing US$ 10.02 million. It is projected to garner US$ 20.50 million by 2028 to expand at 12.7% CAGR during 2022–2028.
Based on application, the market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rehumatology, sports medicine, and others. The aesthetic medicine segment held 55.5% share of Asia Pacific carboxy therapy market in 2022, amassing US$ 11.74 million. It is projected to garner US$ 24.09 million by 2028 to expand at 12.7% CAGR during 2022–2028. The aesthetic medicine segment is further subsegmented into cellulite, stretch marks, alopecia, and dark under-eye circles.
Based on end user, the market is segmented into hospitals, aesthetic clinics, and wellness center. The hospitals segment held 49.3% share of Asia Pacific carboxy therapy market in 2022, amassing US$ 10.43 million. It is projected to garner US$ 21.32 million by 2028 to expand at 12.7% CAGR during 2022–2028.
Based on country, the Asia Pacific carboxy therapy market has been categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.6% share of Asia Pacific carboxy therapy market in 2022. It was assessed at US$ 6.26 million in 2022 and is likely to hit US$ 12.88 million by 2028, exhibiting a CAGR of 12.8% during the forecast period.
Key players profiles in the Asia Pacific carboxy therapy market report are Carbossiterapia Italiana; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; and Mezopharma, among others.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: firstname.lastname@example.org